Download presentation
Presentation is loading. Please wait.
Published byVictor Sintra Modified over 5 years ago
1
In vitro release of corticosteroids in a new model of slow release platform in the treatment of osteoarthritis. S. Colen, M. van Rijen, S. Plomp, L. Creemers Osteoarthritis and Cartilage Volume 22, Pages S389-S390 (April 2014) DOI: /j.joca Copyright © Terms and Conditions
2
Table 1: PGE2-levels of all situations compared to PGE2-levels of chondrocytes treated with TNF-alpha Osteoarthritis and Cartilage , S389-S390DOI: ( /j.joca ) Copyright © Terms and Conditions
3
Table 2: PGE2-levels after TNF-alpha + TA -7 and MS -7 compared to PGE2-levels after TNF-alpha
Osteoarthritis and Cartilage , S389-S390DOI: ( /j.joca ) Copyright © Terms and Conditions
4
Table 3: PGE2-levels of negative control and no TNF-alpha and empty MS compared to PGE2-levels of chondrocytes treated with TNF-alpha Osteoarthritis and Cartilage , S389-S390DOI: ( /j.joca ) Copyright © Terms and Conditions
5
Table 4: PGE2-levels of chondrocytes treated with TNF-alpha and MS compared to PGE2-levels of chondrocytes treated with TNF-alpha Osteoarthritis and Cartilage , S389-S390DOI: ( /j.joca ) Copyright © Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.